A comprehensive systematic literature review of the burden of illness of Lennox–Gastaut syndrome on patients, caregivers, and society

Fully elucidating the burden that Lennox–Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes and quality of life (QoL). This systematic literature review evaluated the global burden of illness of LGS, including clinical symptom burden,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Epilepsia (Copenhagen) Jg. 65; H. 5; S. 1224 - 1239
Hauptverfasser:	Cross, J. Helen, Benítez, Arturo, Roth, Jeannine, Andrews, J. Scott, Shah, Drishti, Butcher, Emma, Jones, Aimee, Sullivan, Joseph
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Wiley Subscription Services, Inc 01.05.2024
Schlagworte:	caregiver burden Caregiver Burden - psychology Caregivers Caregivers - economics Caregivers - psychology comorbidities Comorbidity Cost of Illness Drug resistance Humans Intellectual disabilities Intellectual Disability - economics Intellectual Disability - epidemiology Intellectual Disability - psychology Intellectual Disability - therapy Lennox Gastaut Syndrome Literature reviews nonseizure symptoms Quality of Life Seizures Sleep disorders Social interactions symptom burden Systematic review symptom burden comorbidities nonseizure symptoms caregiver burden
ISSN:	0013-9580, 1528-1167, 1528-1167
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Fully elucidating the burden that Lennox–Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes and quality of life (QoL). This systematic literature review evaluated the global burden of illness of LGS, including clinical symptom burden, care requirements, QoL, comorbidities, caregiver burden, economic burden, and treatment burden (PROSPERO ID: CRD42022317413). MEDLINE, Embase, and the Cochrane Library were searched for articles that met predetermined criteria. After screening 1442 deduplicated articles and supplementary manual searches, 113 articles were included for review. A high clinical symptom burden of LGS was identified, with high seizure frequency and nonseizure symptoms (including developmental delay and intellectual disability) leading to low QoL and substantial care requirements for individuals with LGS, with the latter including daily function assistance for mobility, eating, and toileting. Multiple comorbidities were identified, with intellectual disorders having the highest prevalence. Although based on few studies, a high caregiver burden was also identified, which was associated with physical problems (including fatigue and sleep disturbances), social isolation, poor mental health, and financial difficulties. Most economic analyses focused on the high direct costs of LGS, which arose predominantly from medically treated seizure events, inpatient costs, and medication requirements. Pharmacoresistance was common, and many individuals required polytherapy and treatment changes over time. Few studies focused on the humanistic burden. Quality concerns were noted for sample representativeness, disease and outcome measures, and reporting clarity. In summary, a high burden of LGS on individuals, caregivers, and health care systems was identified, which may be alleviated by reducing the clinical symptom burden. These findings highlight the need for a greater understanding of and better definitions for the broad spectrum of LGS symptoms and development of treatments to alleviate nonseizure symptoms.
AbstractList	Fully elucidating the burden that Lennox-Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes and quality of life (QoL). This systematic literature review evaluated the global burden of illness of LGS, including clinical symptom burden, care requirements, QoL, comorbidities, caregiver burden, economic burden, and treatment burden (PROSPERO ID: CRD42022317413). MEDLINE, Embase, and the Cochrane Library were searched for articles that met predetermined criteria. After screening 1442 deduplicated articles and supplementary manual searches, 113 articles were included for review. A high clinical symptom burden of LGS was identified, with high seizure frequency and nonseizure symptoms (including developmental delay and intellectual disability) leading to low QoL and substantial care requirements for individuals with LGS, with the latter including daily function assistance for mobility, eating, and toileting. Multiple comorbidities were identified, with intellectual disorders having the highest prevalence. Although based on few studies, a high caregiver burden was also identified, which was associated with physical problems (including fatigue and sleep disturbances), social isolation, poor mental health, and financial difficulties. Most economic analyses focused on the high direct costs of LGS, which arose predominantly from medically treated seizure events, inpatient costs, and medication requirements. Pharmacoresistance was common, and many individuals required polytherapy and treatment changes over time. Few studies focused on the humanistic burden. Quality concerns were noted for sample representativeness, disease and outcome measures, and reporting clarity. In summary, a high burden of LGS on individuals, caregivers, and health care systems was identified, which may be alleviated by reducing the clinical symptom burden. These findings highlight the need for a greater understanding of and better definitions for the broad spectrum of LGS symptoms and development of treatments to alleviate nonseizure symptoms. Fully elucidating the burden that Lennox-Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes and quality of life (QoL). This systematic literature review evaluated the global burden of illness of LGS, including clinical symptom burden, care requirements, QoL, comorbidities, caregiver burden, economic burden, and treatment burden (PROSPERO ID: CRD42022317413). MEDLINE, Embase, and the Cochrane Library were searched for articles that met predetermined criteria. After screening 1442 deduplicated articles and supplementary manual searches, 113 articles were included for review. A high clinical symptom burden of LGS was identified, with high seizure frequency and nonseizure symptoms (including developmental delay and intellectual disability) leading to low QoL and substantial care requirements for individuals with LGS, with the latter including daily function assistance for mobility, eating, and toileting. Multiple comorbidities were identified, with intellectual disorders having the highest prevalence. Although based on few studies, a high caregiver burden was also identified, which was associated with physical problems (including fatigue and sleep disturbances), social isolation, poor mental health, and financial difficulties. Most economic analyses focused on the high direct costs of LGS, which arose predominantly from medically treated seizure events, inpatient costs, and medication requirements. Pharmacoresistance was common, and many individuals required polytherapy and treatment changes over time. Few studies focused on the humanistic burden. Quality concerns were noted for sample representativeness, disease and outcome measures, and reporting clarity. In summary, a high burden of LGS on individuals, caregivers, and health care systems was identified, which may be alleviated by reducing the clinical symptom burden. These findings highlight the need for a greater understanding of and better definitions for the broad spectrum of LGS symptoms and development of treatments to alleviate nonseizure symptoms.Fully elucidating the burden that Lennox-Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes and quality of life (QoL). This systematic literature review evaluated the global burden of illness of LGS, including clinical symptom burden, care requirements, QoL, comorbidities, caregiver burden, economic burden, and treatment burden (PROSPERO ID: CRD42022317413). MEDLINE, Embase, and the Cochrane Library were searched for articles that met predetermined criteria. After screening 1442 deduplicated articles and supplementary manual searches, 113 articles were included for review. A high clinical symptom burden of LGS was identified, with high seizure frequency and nonseizure symptoms (including developmental delay and intellectual disability) leading to low QoL and substantial care requirements for individuals with LGS, with the latter including daily function assistance for mobility, eating, and toileting. Multiple comorbidities were identified, with intellectual disorders having the highest prevalence. Although based on few studies, a high caregiver burden was also identified, which was associated with physical problems (including fatigue and sleep disturbances), social isolation, poor mental health, and financial difficulties. Most economic analyses focused on the high direct costs of LGS, which arose predominantly from medically treated seizure events, inpatient costs, and medication requirements. Pharmacoresistance was common, and many individuals required polytherapy and treatment changes over time. Few studies focused on the humanistic burden. Quality concerns were noted for sample representativeness, disease and outcome measures, and reporting clarity. In summary, a high burden of LGS on individuals, caregivers, and health care systems was identified, which may be alleviated by reducing the clinical symptom burden. These findings highlight the need for a greater understanding of and better definitions for the broad spectrum of LGS symptoms and development of treatments to alleviate nonseizure symptoms.
Author	Butcher, Emma Jones, Aimee Benítez, Arturo Andrews, J. Scott Roth, Jeannine Cross, J. Helen Shah, Drishti Sullivan, Joseph
Author_xml	– sequence: 1 givenname: J. Helen orcidid: 0000-0001-7345-4829 surname: Cross fullname: Cross, J. Helen organization: University College London National Institute for Health and Care Research Biomedical Research Centre Great Ormond Street Institute of Child Health – sequence: 2 givenname: Arturo surname: Benítez fullname: Benítez, Arturo organization: Takeda Pharmaceutical Company – sequence: 3 givenname: Jeannine surname: Roth fullname: Roth, Jeannine organization: Takeda Pharmaceuticals International – sequence: 4 givenname: J. Scott surname: Andrews fullname: Andrews, J. Scott organization: Takeda Pharmaceutical Company – sequence: 5 givenname: Drishti surname: Shah fullname: Shah, Drishti organization: Takeda Pharmaceutical Company – sequence: 6 givenname: Emma surname: Butcher fullname: Butcher, Emma organization: Oxford PharmaGenesis – sequence: 7 givenname: Aimee orcidid: 0000-0003-0279-1814 surname: Jones fullname: Jones, Aimee organization: Oxford PharmaGenesis – sequence: 8 givenname: Joseph orcidid: 0000-0003-2081-8988 surname: Sullivan fullname: Sullivan, Joseph email: joseph.sullivan@ucsf.edu organization: University of California, San Francisco
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/38456647$$D View this record in MEDLINE/PubMed
BookMark	eNp1kc1O3DAUha2Kqgy0C16gssSmSA34J7GTJUIUkEZqF7C2HOcGjBI72A50dt31AfqGPAmezrBBrWXJ19J3zr26Zw_tOO8AoQNKjmk-JzDZYyobzt6hBa1YXVAq5A5aEEJ50VQ12UV7Md4TQqSQ_APa5XVZCVHKBfp9io0fpwB34KJ9BBxXMcGokzV4sAmCTnMAHODRwhP2PU53gNs5dODWPzsMDmJcl0twzv98_vXnQsek55SdXBf8CNg7PGVDcCl-xUYHuM2NQq6163D0xkJafUTvez1E-LR999HNt_Prs8ti-f3i6ux0WRhe16yoQXLNmOatloZTJlog0OuurTrT9kBrw5iAsqG8okb3hBoiW80FM23DKy34Pvqy8Z2Cf5ghJjXaaGAYtAM_R8WaqpRSlExm9PANeu_n4PJ0ipOK03x5manPW2puR-jUFOyow0q9rjgDJxvABB9jgF4Zm_I6vEtB20FRotYhqhyi-htiVhy9Ubya_ovduj_ZAVb_B9X5j6uN4gWND65s
CitedBy_id	crossref_primary_10_2147_RMHP_S519367 crossref_primary_10_1016_j_yebeh_2025_110644 crossref_primary_10_1111_epi_18289 crossref_primary_10_3390_children11080905 crossref_primary_10_1080_17425255_2025_2510302 crossref_primary_10_1002_epi4_70144 crossref_primary_10_1007_s40263_025_01201_8 crossref_primary_10_1186_s12916_025_03972_9 crossref_primary_10_1055_a_2534_3267 crossref_primary_10_1016_j_eplepsyres_2024_107499 crossref_primary_10_1016_j_seizure_2025_04_017 crossref_primary_10_1002_epi4_70118 crossref_primary_10_1002_epi4_13075 crossref_primary_10_1002_epi4_70069 crossref_primary_10_1007_s40263_024_01149_1 crossref_primary_10_1016_j_yebeh_2025_110272
Cites_doi	10.1055/s-2000-7456 10.1097/WNF.0b013e3182770730 10.13105/wjma.v5.i4.80 10.1016/j.eplepsyres.2015.02.003 10.1016/j.seizure.2021.05.025 10.1111/j.1528-1157.2000.tb00179.x 10.1016/S1059-1311(05)80124-4 10.1111/epi.13692 10.4103/0976-3147.203820 10.1177/155005949202300407 10.1016/j.yebeh.2020.107647 10.1111/j.1469-8749.2012.04233.x 10.2147/JMDH.S69300 10.7326/0003-4819-147-8-200710160-00010 10.1016/j.seizure.2021.02.015 10.1111/j.1528-1157.1984.tb04172.x 10.1016/S0920-1211(01)00280-7 10.1177/0883073817714394 10.1111/epi.12567 10.1136/bmj.n71 10.1016/j.seizure.2009.10.007 10.1016/j.jval.2019.04.1307 10.1016/j.jval.2016.03.212 10.1177/1756286419897813 10.1212/CPJ.0000000000000992 10.1016/j.yebeh.2019.01.045 10.1016/j.eplepsyres.2021.106813 10.1111/j.1528-1157.1996.tb01820.x 10.1016/j.vhri.2020.07.402 10.1016/j.yebeh.2021.108239 10.1136/bmjopen-2016-011458 10.1016/S0387-7604(87)80098-0 10.1111/j.1528-1157.1996.tb01821.x 10.1016/j.yebeh.2017.09.006 10.1016/j.eplepsyres.2010.01.012 10.1016/j.yebeh.2017.08.026 10.1016/j.braindev.2007.09.004 10.1016/j.seizure.2009.06.005 10.1016/j.ejpn.2004.08.002 10.1542/peds.2018-0449 10.1111/epi.13368 10.1053/seiz.2000.0483 10.1007/s00701-016-2765-9 10.3389/fneur.2017.00505 10.1111/epi.16934 10.1016/j.yebeh.2009.07.038 10.1016/j.eplepsyres.2014.11.004 10.1016/j.braindev.2018.07.020 10.1016/j.yebeh.2020.107287 10.1016/j.jns.2013.07.057 10.1016/j.seizure.2011.02.011 10.1016/j.yebeh.2020.107253 10.1016/j.jval.2012.03.772 10.1016/j.seizure.2015.10.009 10.1212/WNL.36.9.1224 10.1016/j.yebeh.2017.05.021 10.1002/epi4.12470 10.1016/j.yebeh.2022.108586 10.4103/1817-1745.159184 10.4274/tpa.634 10.1212/WNL.92.15_supplement.P2.5-011 10.1007/s40263-020-00784-8 10.1016/j.ebr.2021.100508 10.1111/ane.12221 10.1186/s11689-018-9229-x 10.1016/j.yebeh.2013.08.011 10.1186/s13023-023-02626-4 10.1016/j.pediatrneurol.2013.03.016 10.1212/CPJ.0000000000000527 10.1046/j.1528-1157.2001.23900.x 10.1111/j.1528-1157.1997.tb00065.x 10.3389/fneur.2020.00409 10.1016/j.seizure.2012.08.003 10.3349/ymj.2019.60.1.106 10.1016/j.eplepsyres.2018.09.011 10.1016/j.braindev.2007.07.013 10.1016/j.eplepsyres.2021.106575 10.1111/epi.17241 10.1007/s10072-017-3188-y 10.1111/epi.14569 10.1016/j.jval.2019.04.1300 10.1212/WNL.90.15_supplement.P2.087 10.1100/2012/614263 10.1111/epi.13670 10.1016/j.clineuro.2012.09.021
ContentType	Journal Article
Copyright	2024 The Authors. published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. 2024 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: 2024 The Authors. published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. – notice: 2024 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. – notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7X8
DOI	10.1111/epi.17932
DatabaseName	Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic
DatabaseTitleList	MEDLINE CrossRef Neurosciences Abstracts MEDLINE - Academic
Database_xml	– sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1528-1167
EndPage	1239
ExternalDocumentID	38456647 10_1111_epi_17932 EPI17932
Genre	reviewArticle Research Support, Non-U.S. Gov't Systematic Review Journal Article
GrantInformation_xml	– fundername: Takeda Pharmaceutical Company
GroupedDBID	--- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29G 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAGKA AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AI. AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FYBCS G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7TK 7X8
ID	FETCH-LOGICAL-c3882-8e73a22a3ba7c3126be0efadb5dcbfe18c226e491351caf01c07ba362cb935a63
IEDL.DBID	24P
ISICitedReferencesCount	18
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001180691300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0013-9580 1528-1167
IngestDate	Sun Nov 09 12:02:03 EST 2025 Wed Aug 13 08:48:06 EDT 2025 Sun Jul 13 01:33:06 EDT 2025 Sat Nov 29 05:19:11 EST 2025 Tue Nov 18 22:33:16 EST 2025 Sun Jul 06 04:45:34 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Keywords	symptom burden comorbidities nonseizure symptoms caregiver burden
Language	English
License	Attribution-NonCommercial-NoDerivs 2024 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c3882-8e73a22a3ba7c3126be0efadb5dcbfe18c226e491351caf01c07ba362cb935a63
Notes	Affiliations for Jeannine Roth and Emma Butcher were at the indicated institutions at the time the study was conducted. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-4 content type line 23 ObjectType-Undefined-3
ORCID	0000-0003-0279-1814 0000-0001-7345-4829 0000-0003-2081-8988
OpenAccessLink	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fepi.17932
PMID	38456647
PQID	3053153134
PQPubID	1066359
PageCount	16
ParticipantIDs	proquest_miscellaneous_2954776427 proquest_journals_3053153134 pubmed_primary_38456647 crossref_citationtrail_10_1111_epi_17932 crossref_primary_10_1111_epi_17932 wiley_primary_10_1111_epi_17932_EPI17932
PublicationCentury	2000
PublicationDate	May 2024 2024-05-00 2024-May 20240501
PublicationDateYYYYMMDD	2024-05-01
PublicationDate_xml	– month: 05 year: 2024 text: May 2024
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: Hoboken
PublicationTitle	Epilepsia (Copenhagen)
PublicationTitleAlternate	Epilepsia
PublicationYear	2024
Publisher	Wiley Subscription Services, Inc
Publisher_xml	– name: Wiley Subscription Services, Inc
References	2019; 93 2010; 19 2004; 8 2011; 52 2020; 13 2018; 40 2020; 11 2008; 30 2012; 15 2012; 12 2001; 46 1997; 9 2001; 42 2014; 129 2017; 73 2018; 39 2018; 8 1997; 51 1995; 26 2015; 84 2019; 22 2017; 77 2017; 76 2013; 115 2014; 16 2014; 14 2016; 158 2014; 17 2003; 41 2016; 48 2012; 21 2009; 16 2018; 37 2009; 18 2011; 258 2015; 56 2016; 19 2007; 16 2017; 58 2015; 112 2015; 63 2015; 110 1997; 38 2013; 333 2012; 47 2018; 10 1992; 23 2021; 62 2016; 8 2010; 50 2017; 5 2013; 29 2017; 8 2012; 2012 2017; 3 1984; 25 1987; 9 2021; 123 2021; 29 2000; 41 1986; 36 2015; 33 2022; 63 1996; 37 1993; 2 2012; 54 2021; 35 2019; 60 2009; 50 2021; 115 2017; 32 2011; 20 2014; 7 2022; 128 2014; 55 2001; 10 1981; 33 2018; 142 2021; 6 2021; 86 2013; 49 2023; 18 2006; 11 2015; 10 2018; 147 2016; 57 2021; 91 2010; 89 1988; 1 2021; 16 2013; 36 2021; 11 2021; 178 2000; 31 2015; 21 2019 2018 2021; 172 2020; 111 2018; 59 e_1_2_11_70_1 e_1_2_11_93_1 Deering L (e_1_2_11_18_1) 2019 Oggioni GD (e_1_2_11_106_1) 2014; 55 e_1_2_11_32_1 e_1_2_11_55_1 e_1_2_11_78_1 e_1_2_11_51_1 e_1_2_11_74_1 e_1_2_11_97_1 e_1_2_11_13_1 e_1_2_11_29_1 Milovanovic M (e_1_2_11_64_1) 2014; 55 e_1_2_11_4_1 e_1_2_11_48_1 e_1_2_11_102_1 Widdess‐Walsh P (e_1_2_11_23_1) 2012; 12 Ren LK (e_1_2_11_36_1) 2003; 41 e_1_2_11_66_1 e_1_2_11_47_1 e_1_2_11_89_1 e_1_2_11_24_1 e_1_2_11_8_1 e_1_2_11_43_1 e_1_2_11_17_1 Brinciotti M (e_1_2_11_60_1) 1981; 33 e_1_2_11_59_1 Segovia BL (e_1_2_11_82_1) 2017; 3 e_1_2_11_113_1 Dixon‐Salazar T (e_1_2_11_69_1) 2018 Rodriguez‐Rodriguez S (e_1_2_11_35_1) 2011; 52 Pina‐Garza JE (e_1_2_11_85_1) 2015; 84 e_1_2_11_92_1 e_1_2_11_77_1 e_1_2_11_73_1 e_1_2_11_12_1 e_1_2_11_54_1 e_1_2_11_96_1 e_1_2_11_103_1 e_1_2_11_28_1 e_1_2_11_5_1 Rodriguez Mendoza M (e_1_2_11_42_1) 2014; 16 e_1_2_11_61_1 e_1_2_11_80_1 e_1_2_11_46_1 Hsairi I (e_1_2_11_76_1) 2011; 258 e_1_2_11_107_1 e_1_2_11_9_1 Nikanorova M (e_1_2_11_20_1) 2009; 50 e_1_2_11_65_1 e_1_2_11_84_1 Auvin S (e_1_2_11_98_1) 2014; 55 e_1_2_11_114_1 e_1_2_11_16_1 e_1_2_11_39_1 e_1_2_11_91_1 Ouedraogo PV (e_1_2_11_34_1) 2018; 37 e_1_2_11_30_1 e_1_2_11_57_1 e_1_2_11_99_1 Soto A (e_1_2_11_52_1) 2014; 14 Herranz JL (e_1_2_11_31_1) 2010; 50 Oka E (e_1_2_11_58_1) 1997; 51 e_1_2_11_53_1 e_1_2_11_11_1 e_1_2_11_6_1 e_1_2_11_27_1 Takayama R (e_1_2_11_110_1) 2016; 48 e_1_2_11_2_1 e_1_2_11_100_1 Habib HS (e_1_2_11_75_1) 2006; 11 Kim SH (e_1_2_11_116_1) 2011; 52 Kwon S (e_1_2_11_117_1) 2015; 56 e_1_2_11_83_1 e_1_2_11_45_1 e_1_2_11_68_1 e_1_2_11_41_1 e_1_2_11_87_1 e_1_2_11_108_1 Uysal U (e_1_2_11_62_1) 2012; 12 e_1_2_11_22_1 Rathaur BPS (e_1_2_11_67_1) 2014; 17 e_1_2_11_115_1 e_1_2_11_111_1 e_1_2_11_38_1 e_1_2_11_19_1 Nikanorova M (e_1_2_11_50_1) 2011; 52 Velasco M (e_1_2_11_81_1) 1995; 26 e_1_2_11_94_1 e_1_2_11_71_1 e_1_2_11_90_1 Kieffer‐Renaux V (e_1_2_11_72_1) 1997; 9 e_1_2_11_10_1 e_1_2_11_56_1 e_1_2_11_79_1 e_1_2_11_14_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_105_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_49_1 e_1_2_11_101_1 Furune S (e_1_2_11_21_1) 1988; 1 e_1_2_11_44_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_63_1 e_1_2_11_86_1 Cramer J (e_1_2_11_88_1) 2009; 50 e_1_2_11_109_1 Downes MJ (e_1_2_11_15_1) 2016; 8 e_1_2_11_37_1 Li X (e_1_2_11_95_1) 2015; 21 e_1_2_11_112_1 Shih EJ (e_1_2_11_104_1) 2015; 63
References_xml	– volume: 258 start-page: S234 year: 2011 article-title: Childhood epileptic encephalopathies: cognitive and behavioural aspects publication-title: J Neurol – volume: 33 start-page: 81 year: 2015 end-page: 87 article-title: Efficacy and tolerability of add‐on Lacosamide treatment in adults with Lennox–Gastaut syndrome: an observational study publication-title: Seizure – volume: 29 issue: 372 year: 2021 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ – volume: 25 start-page: 161 year: 1984 end-page: 167 article-title: Alertness and incidence of seizures in patients with Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 55 start-page: 211 year: 2014 article-title: Lennox‐Gastaut syndrome in adulthood: clinical features from a long term follow‐up publication-title: Epilepsia – volume: 172 year: 2021 article-title: The unchanging face of Lennox‐Gastaut syndrome in adulthood publication-title: Epilepsy Res – volume: 31 start-page: 169 year: 2000 end-page: 174 article-title: Nonconvulsive status epilepticus—a possible cause of mental retardation in patients with Lennox‐Gastaut syndrome publication-title: Neuropediatrics – volume: 37 start-page: 44 year: 1996 end-page: 47 article-title: Long‐term prognosis of Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 333 year: 2013 article-title: Ketogenic diet efficacy in children with Lennox–Gastaut syndrome publication-title: J Neurol Sci – volume: 129 start-page: 420 year: 2014 end-page: 424 article-title: Efficacy and tolerability of add‐on lacosamide in children with Lennox‐Gastaut syndrome publication-title: Acta Neurol Scand – volume: 36 start-page: 4 year: 2013 end-page: 7 article-title: Long‐term use of Clobazam in Lennox‐Gastaut syndrome: experience in a single tertiary epilepsy center publication-title: Clin Neuropharmacol – volume: 9 start-page: 627 year: 1987 end-page: 635 article-title: Overnight polygraphic study of Lennox‐Gastaut syndrome publication-title: Brain and Development – volume: 56 start-page: 169 year: 2015 end-page: 170 article-title: Effectiveness and tolerability of rufinamide in Korean children with Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 54 start-page: 464 year: 2012 end-page: 468 article-title: Efficacy of the ketogenic diet in Lennox‐Gastaut syndrome: a retrospective review of one institution's experience and summary of the literature publication-title: Dev Med Child Neurol – volume: 46 start-page: 241 year: 2001 end-page: 250 article-title: Sleep in Lennox‐Gastaut syndrome: the role of the cyclic alternating pattern (CAP) in the gate control of clinical seizures and generalized polyspikes publication-title: Epilepsy Res – volume: 50 start-page: 149 year: 2009 article-title: Electroclinical Semiology at Onset of the Lennox‐Gastaut Syndrome publication-title: Epilepsia – volume: 51 start-page: 173 year: 1997 end-page: 178 article-title: Mental deterioration in childhood epilepsy publication-title: Acta Med Okayama – volume: 8 start-page: 291 year: 2004 end-page: 297 article-title: Behavioural and neuropsychological problems in refractory paediatric epilepsies publication-title: Eur J Peadiratr Neurol – volume: 110 start-page: 10 year: 2015 end-page: 19 article-title: Long‐term prognosis of patients with Lennox—Gastaut syndrome in recent decades publication-title: Epilepsy Res – volume: 21 start-page: S48 year: 2015 article-title: Examining healthcare utilization and costs in patients with lennox‐gastaut syndrome: a real‐world observational study in a U.S. health plan publication-title: J Manag Care Spec Pharm – volume: 16 year: 2021 article-title: Quantifying the burden of disease in patients with Lennox Gastaut syndrome publication-title: Epilepsy Behav Rep – volume: 21 start-page: 760 year: 2012 end-page: 763 article-title: Lennox–Gastaut syndrome in south Iran: electroclinical manifestations publication-title: Seizure – volume: 11 start-page: e669 year: 2021 end-page: e676 article-title: Efficacy and tolerability of Clobazam in adults with drug‐refractory epilepsy publication-title: Neurol Clin Pract – volume: 47 start-page: 47 year: 2012 end-page: 51 article-title: Lennox‐Gastaut sendromlu hastaların klinik özellikleri ve uzun süreli seyri publication-title: Turk Pediatri Arsivi – volume: 33 start-page: 105 year: 1981 end-page: 110 article-title: Prognosis of Lennox‐Gastaut syndrome publication-title: Minerva Pediatr – volume: 38 start-page: 1283 year: 1997 end-page: 1288 article-title: Prevalence and descriptive epidemiology of Lennox‐Gastaut syndrome among Atlanta children publication-title: Epilepsia – volume: 86 start-page: 168 year: 2021 end-page: 174 article-title: The efficacy and tolerability of auto‐stimulation‐VNS in children with Lennox‐Gastaut syndrome publication-title: Seizure – volume: 3 start-page: 3 year: 2017 article-title: Malnutrition, an important comorbidity in patients with Lennox Gastaut syndrome publication-title: J Neurol Neurosurg – volume: 15 start-page: A143 year: 2012 article-title: PND13 economic burden of Lennox‐Gastaut syndrome publication-title: Value Health – year: 2019 – volume: 6 start-page: 206 year: 2021 end-page: 215 article-title: Clinical profile and treatment outcome of epilepsy syndromes in children: a hospital‐based study in eastern Nepal publication-title: Epilepsia Open – volume: 2012 year: 2012 article-title: Surgical treatment of patients with Lennox‐Gastaut syndrome phenotype publication-title: Sci World J – volume: 35 start-page: 61 year: 2021 end-page: 83 article-title: Expanding the treatment landscape for Lennox‐Gastaut syndrome: current and future strategies publication-title: CNS Drugs – volume: 41 start-page: 395 year: 2000 end-page: 399 article-title: Long‐term seizure outcome in 74 patients with Lennox‐Gastaut syndrome: effects of incorporating MRI head imaging in defining the cryptogenic subgroup publication-title: Epilepsia – volume: 2 start-page: 167 year: 1993 end-page: 178 article-title: Coping with the uncertainty of uncontrolled epilepsy publication-title: Seizure – volume: 52 start-page: 132 year: 2011 article-title: A European Registry of antiepileptic drug use in patients with Lennox‐Gastaut syndrome: update of current status publication-title: Epilepsia – volume: 84 start-page: 30 issue: P7 year: 2015 article-title: Development of a claims‐based classifier to identify Lennox‐Gastaut syndrome publication-title: Neurology – volume: 112 start-page: 18 year: 2015 end-page: 26 article-title: Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox–Gastaut syndrome publication-title: Epilepsy Res – volume: 20 start-page: 468 year: 2011 end-page: 474 article-title: Effectiveness of vagal nerve stimulation (VNS) in patients with drop‐attacks and different epileptic syndromes publication-title: Seizure – volume: 55 start-page: 207 year: 2014 end-page: 208 article-title: Lennox‐gastaut syndrome in adult patients publication-title: Epilepsia – volume: 32 start-page: 947 year: 2017 end-page: 955 article-title: Early diagnosis and treatment of Lennox‐Gastaut syndrome publication-title: J Child Neurol – volume: 128 year: 2022 article-title: Rare diseases – rare outcomes: assessing communication abilities for the developmental and epileptic encephalopathies publication-title: Epilepsy Behav – volume: 62 start-page: 1617 year: 2021 end-page: 1628 article-title: Assessing seizure burden in pediatric epilepsy using an electronic medical record‐based tool through a common data element approach publication-title: Epilepsia – volume: 26 start-page: S117 year: 1995 end-page: S125 article-title: Sleep‐epilepsy interactions in patients with intractable generalized tonic seizures and depth electrodes in the centro median thalamic nucleus publication-title: Arch Med Res – volume: 22 start-page: S274 year: 2019 article-title: PND27 economic burden of probable lennox‐gastaut syndrome, probable dravet syndrome, and other refractory epilepsies for United States commercial health plans publication-title: Value Health – volume: 50 start-page: 177 year: 2009 article-title: Domains of concern for families whose child has Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 158 start-page: 1005 year: 2016 end-page: 1012 article-title: Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox‐Gastaut syndrome publication-title: Acta Neurochir – volume: 39 start-page: 403 year: 2018 end-page: 414 article-title: Lennox‐Gastaut syndrome: a comprehensive review publication-title: Neurol Sci – volume: 37 start-page: 24 year: 2018 end-page: 31 article-title: Electro‐Clinical Manifestations of Lennox‐Gastaut syndrome publication-title: Afr J Neurol Sci – volume: 49 start-page: 25 year: 2013 end-page: 30 article-title: Lennox‐Gastaut syndrome symptomatic to hypothalamic hamartoma: evolution and long‐term outcome following surgery publication-title: Pediatr Neurol – volume: 48 start-page: 332 year: 2016 end-page: 336 article-title: Short‐Term Efficacy and Safety of Rufinamide for Lennox‐Gastaut Syndrome publication-title: Brain and Development – volume: 14 start-page: 407 year: 2014 article-title: Vagus nerve stimulation (VNS) therapy in 46 patients with lennox‐gastaut syndrome (LGS) in Venezuela publication-title: Epilepsy Curr – volume: 60 start-page: 106 year: 2019 end-page: 114 article-title: Lennox‐Gastaut syndrome in mitochondrial disease publication-title: Yonsei Med J – volume: 40 start-page: 897 year: 2018 end-page: 903 article-title: Rufinamide efficacy and safety in children aged 1–4 years with Lennox–Gastaut syndrome publication-title: Brain and Development – volume: 59 start-page: 2096 year: 2018 end-page: 2105 article-title: Evolution and course of early life developmental encephalopathic epilepsies: focus on Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 55 start-page: 111 year: 2014 article-title: Use of adjunctive rufinamide for patients with lennox‐gastaut syndrome in clinical practice publication-title: Epilepsia – volume: 111 year: 2020 article-title: Nonseizure consequences of Dravet syndrome, KCNQ2‐DEE, KCNB1‐DEE, Lennox‐Gastaut syndrome, ESES: a functional framework publication-title: Epilepsy Behav – volume: 52 start-page: 257 year: 2011 end-page: 263 article-title: Development of Lennox‐Gastaut syndrome in adulthood publication-title: Rev Neurol – volume: 29 start-page: 285 year: 2013 end-page: 288 article-title: Corpus callosotomy is a valuable therapeutic option for patients with Lennox‐Gastaut syndrome and medically refractory seizures publication-title: Epilepsy Behav – volume: 11 start-page: 24 year: 2006 end-page: 27 article-title: Clinical characteristics and responsiveness to treatment in Lennox‐Gastaut syndrome. A retrospective hospital audit publication-title: Neurosciences – year: 2018 – volume: 16 start-page: 321 year: 2009 end-page: 324 article-title: Long‐term vagus nerve stimulation in the treatment of Lennox–Gastaut syndrome publication-title: Epilepsy Behav – volume: 93 start-page: 65 year: 2019 end-page: 72 article-title: The direct cost of seizure events in severe childhood‐onset epilepsies: a retrospective claims‐based analysis publication-title: Epilepsy Behav – volume: 16 start-page: 573 issue: 147 year: 2007 end-page: 577 article-title: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Ann Intern Med – volume: 19 start-page: A67 year: 2016 end-page: A68 article-title: A life‐course assessment of medication use and medical costs of lennox‐gastaut syndrome (LGS) publication-title: Value Health – volume: 12 start-page: 64 year: 2012 article-title: Prospective analysis of seizure freedom in established epilepsy (Abs 1.160) publication-title: Epilepsy Curr – volume: 8 start-page: 225 year: 2017 end-page: 227 article-title: Lennox‐Gastaut syndrome: a prospective follow‐up study publication-title: J Neurosci Rural Pract – volume: 7 start-page: 441 year: 2014 end-page: 448 article-title: Lennox‐Gastaut syndrome: impact on the caregivers and families of patients publication-title: J Multidiscip Healthc – volume: 23 start-page: 180 year: 1992 end-page: 188 article-title: The Lennox‐Gastaut syndrome: electroencephalographic characteristics, clinical correlates, and follow‐up studies publication-title: Clin EEG Electroencephal – volume: 30 start-page: 287 year: 2008 end-page: 290 article-title: Clinical efficacy of zonisamide in Lennox‐Gastaut syndrome: Korean multicentric experience publication-title: Brain and Development – volume: 57 start-page: 757 year: 2016 end-page: 769 article-title: Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France publication-title: Epilepsia – volume: 19 start-page: 23 year: 2010 end-page: 30 article-title: Lennox‐Gastaut syndrome (LGS): development of conceptual models of health‐related quality of life (HRQL) for caregivers and children publication-title: Seizure – volume: 22 start-page: S276 year: 2019 article-title: PND34 economic burden of probable Lennox‐Gastaut syndrome, probable dravet syndrome, and other refractory epilepsies for united states medicaid health plans publication-title: Value Health – volume: 115 start-page: 926 year: 2013 end-page: 929 article-title: Effectiveness and tolerability of rufinamide in children and young adults with Lennox–Gastaut syndrome: a single center study in Korea publication-title: Clin Neurol Neurosurg – volume: 63 start-page: 1398 year: 2022 end-page: 1442 article-title: International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions publication-title: Epilepsia – volume: 16 start-page: 22 year: 2014 article-title: Effectiveness of the corpus callosotomy as a quirurgical treatment for the Lennox‐Gastaut syndrome publication-title: Epileptic Disord – volume: 5 start-page: 80 year: 2017 end-page: 123 article-title: Assessing the quality of studies in meta‐analyses: advantages and limitations of the Newcastle Ottawa scale publication-title: World J Meta‐Anal – volume: 10 start-page: 98 year: 2015 end-page: 102 article-title: Relationship of Lennox‐Gastaut syndrome with perinatal event: a cross‐sectional study publication-title: J Pediatr Neurosci – volume: 8 issue: 6 year: 2016 article-title: Development of a critical appraisal tool to assess the quality of cross‐sectional studies (AXIS) publication-title: BMJ Open – volume: 10 start-page: 10 year: 2018 article-title: Few individuals with Lennox‐Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome publication-title: J Neurodev Disord – volume: 37 start-page: 48 year: 1996 end-page: 51 article-title: Evolution of Lennox‐Gastaut syndrome: a long‐term longitudinal study publication-title: Epilepsia – volume: 41 start-page: 7 year: 2003 end-page: 10 article-title: Characteristics of clinical manifestations and EEG of Lennox‐Gastaut syndrome publication-title: J Pediatr – volume: 178 year: 2021 article-title: Long‐term medical and social outcomes of patients with Lennox‐Gastaut syndrome publication-title: Epilepsy Res – volume: 111 year: 2020 article-title: Vagus nerve stimulation in patients with therapy‐resistant generalized epilepsy publication-title: Epilepsy Behav – volume: 142 year: 2018 article-title: Long‐term outcome of resective epilepsy surgery in patients with Lennox‐Gastaut syndrome publication-title: Pediatrics – volume: 58 start-page: e44 year: 2017 end-page: e48 article-title: Adult motor phenotype differentiates Dravet syndrome from Lennox‐Gastaut syndrome and links SCN1A to early onset parkinsonian features publication-title: Epilepsia – volume: 42 start-page: 1148 year: 2001 end-page: 1152 article-title: Vagus nerve stimulation in children with refractory seizures associated with Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 36 start-page: 1224 year: 1986 end-page: 1226 article-title: Sleep patterns in the Lennox‐Gastaut syndrome publication-title: Neurology – volume: 89 start-page: 271 year: 2010 end-page: 277 article-title: Lennox‐Gastaut syndrome in adulthood: clinical and EEG features publication-title: Epilepsy Res – volume: 63 start-page: 180 year: 2015 end-page: 181 article-title: The ketogenic diet in the treatment of highly refractive infantile spasms and lennox‐gastaut syndrome publication-title: J Investig Med – volume: 18 start-page: 42 year: 2023 article-title: The burden of illness in Lennox–Gastaut syndrome: a systematic literature review publication-title: Orphanet J Rare Dis – volume: 77 start-page: 73 year: 2017 end-page: 78 article-title: Lennox‐Gastaut syndrome in adulthood: long‐term clinical follow‐up of 38 patients and analysis of their recorded seizures publication-title: Epilepsy Behav – volume: 50 start-page: 711 year: 2010 end-page: 717 article-title: Lennox‐Gastaut syndrome in Spain: a descriptive retrospective epidemiological study publication-title: Rev Neurol – volume: 115 year: 2021 article-title: Epidemiology, healthcare resource use, and mortality in patients with probable Lennox‐Gastaut syndrome: a population‐based study on German health insurance data publication-title: Epilepsy Behav – volume: 17 start-page: S203 year: 2014 end-page: S204 article-title: Clinical demographic profile and outcome of patients with Lennox‐Gastaut syndrome (LGS) publication-title: Ann Indian Acad Neurol – volume: 8 start-page: 505 year: 2017 article-title: Expert opinion on the Management of Lennox–Gastaut Syndrome: treatment algorithms and practical considerations publication-title: Front Neurol – volume: 55 start-page: 4 issue: Suppl 4 year: 2014 end-page: 9 article-title: Lennox‐Gastaut syndrome: a consensus approach to differential diagnosis publication-title: Epilepsia – volume: 1 start-page: 146 year: 1988 end-page: 153 article-title: Long‐term prognosis and clinico‐electroencephalographic evolution of Lennox‐Gastaut syndrome publication-title: Brain Dysfunction – volume: 8 start-page: 397 year: 2018 end-page: 402 article-title: Late‐onset Lennox‐Gastaut syndrome: diagnostic evaluation and outcome publication-title: Neurol Clin Pract – volume: 147 start-page: 95 year: 2018 end-page: 101 article-title: Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic‐atonic seizures publication-title: Seizures Epilepsy Res – volume: 52 start-page: 209 year: 2011 article-title: Adjunctive therapy of rufinamide in Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 13 year: 2020 article-title: Effective and safe diet therapies for Lennox‐Gastaut syndrome with mitochondrial dysfunction publication-title: Ther Adv Neurol Disord – volume: 30 start-page: 195 year: 2008 end-page: 199 article-title: Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox‐Gastaut syndrome publication-title: Brain and Development – volume: 10 start-page: 197 year: 2001 end-page: 202 article-title: Long‐term follow‐up study of Lennox–Gastaut syndrome in patients with severe motor and intellectual disabilities: with special reference to the problem of dysphagia publication-title: Seizure – volume: 9 start-page: 84 year: 1997 end-page: 88 article-title: Neuropsychological outcome of children with Lennox‐Gastaut and doose syndromes publication-title: ANAE – volume: 58 start-page: 522 year: 2017 end-page: 530 article-title: Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE Commission for Classification and Terminology publication-title: Epilepsia – volume: 12 start-page: 60 year: 2012 article-title: Cryptogenic lennox‐gastaut syndrome: phenotypic characteristics of participants in the epilepsy phenome/genome project publication-title: Epilepsy Curr – volume: 76 start-page: 63 year: 2017 end-page: 70 article-title: Real‐world data on rufinamide treatment in patients with Lennox‐Gastaut syndrome: results from a European noninterventional registry study publication-title: Epilepsy Behav – volume: 73 start-page: 46 year: 2017 end-page: 50 article-title: Assessment of treatment patterns and healthcare costs associated with probable Lennox‐Gastaut syndrome publication-title: Epilepsy Behav – volume: 91 start-page: 159 year: 2021 end-page: 166 article-title: Prevalence, healthcare resource utilization and mortality of Lennox‐Gastaut syndrome: retrospective linkage cohort study publication-title: Seizure – volume: 18 start-page: 554 year: 2009 end-page: 558 article-title: Impact of Lennox‐Gastaut syndrome (LGS) on health‐related quality of life (HRQL) of patients and caregivers: literature review publication-title: Seizure – volume: 11 start-page: 409 year: 2020 article-title: Characterization of anti‐seizure medication treatment pathways in pediatric epilepsy using the electronic health record‐based common data model publication-title: Front Neurol – volume: 123 year: 2021 article-title: The impact of seizure frequency on quality of life in patients with Lennox‐Gastaut syndrome or Dravet syndrome publication-title: Epilepsy Behav – ident: e_1_2_11_22_1 doi: 10.1055/s-2000-7456 – ident: e_1_2_11_99_1 doi: 10.1097/WNF.0b013e3182770730 – ident: e_1_2_11_16_1 doi: 10.13105/wjma.v5.i4.80 – ident: e_1_2_11_40_1 doi: 10.1016/j.eplepsyres.2015.02.003 – ident: e_1_2_11_94_1 doi: 10.1016/j.seizure.2021.05.025 – ident: e_1_2_11_63_1 doi: 10.1111/j.1528-1157.2000.tb00179.x – ident: e_1_2_11_89_1 doi: 10.1016/S1059-1311(05)80124-4 – ident: e_1_2_11_101_1 doi: 10.1111/epi.13692 – ident: e_1_2_11_100_1 doi: 10.4103/0976-3147.203820 – volume: 11 start-page: 24 year: 2006 ident: e_1_2_11_75_1 article-title: Clinical characteristics and responsiveness to treatment in Lennox‐Gastaut syndrome. A retrospective hospital audit publication-title: Neurosciences – volume-title: Lennox‐Gastaut syndrome: characteristics and major caregiver concerns (LGS) year: 2018 ident: e_1_2_11_69_1 – volume: 9 start-page: 84 year: 1997 ident: e_1_2_11_72_1 article-title: Neuropsychological outcome of children with Lennox‐Gastaut and doose syndromes publication-title: ANAE – ident: e_1_2_11_30_1 doi: 10.1177/155005949202300407 – ident: e_1_2_11_73_1 doi: 10.1016/j.yebeh.2020.107647 – ident: e_1_2_11_24_1 doi: 10.1111/j.1469-8749.2012.04233.x – volume: 48 start-page: 332 year: 2016 ident: e_1_2_11_110_1 article-title: Short‐Term Efficacy and Safety of Rufinamide for Lennox‐Gastaut Syndrome publication-title: Brain and Development – ident: e_1_2_11_11_1 doi: 10.2147/JMDH.S69300 – ident: e_1_2_11_14_1 doi: 10.7326/0003-4819-147-8-200710160-00010 – ident: e_1_2_11_105_1 doi: 10.1016/j.seizure.2021.02.015 – volume: 3 start-page: 3 year: 2017 ident: e_1_2_11_82_1 article-title: Malnutrition, an important comorbidity in patients with Lennox Gastaut syndrome publication-title: J Neurol Neurosurg – ident: e_1_2_11_47_1 doi: 10.1111/j.1528-1157.1984.tb04172.x – ident: e_1_2_11_80_1 doi: 10.1016/S0920-1211(01)00280-7 – ident: e_1_2_11_6_1 doi: 10.1177/0883073817714394 – ident: e_1_2_11_5_1 doi: 10.1111/epi.12567 – ident: e_1_2_11_13_1 doi: 10.1136/bmj.n71 – volume: 63 start-page: 180 year: 2015 ident: e_1_2_11_104_1 article-title: The ketogenic diet in the treatment of highly refractive infantile spasms and lennox‐gastaut syndrome publication-title: J Investig Med – ident: e_1_2_11_10_1 doi: 10.1016/j.seizure.2009.10.007 – volume: 14 start-page: 407 year: 2014 ident: e_1_2_11_52_1 article-title: Vagus nerve stimulation (VNS) therapy in 46 patients with lennox‐gastaut syndrome (LGS) in Venezuela publication-title: Epilepsy Curr – ident: e_1_2_11_93_1 doi: 10.1016/j.jval.2019.04.1307 – ident: e_1_2_11_92_1 doi: 10.1016/j.jval.2016.03.212 – ident: e_1_2_11_57_1 doi: 10.1177/1756286419897813 – ident: e_1_2_11_55_1 doi: 10.1212/CPJ.0000000000000992 – ident: e_1_2_11_68_1 doi: 10.1016/j.yebeh.2019.01.045 – ident: e_1_2_11_39_1 doi: 10.1016/j.eplepsyres.2021.106813 – volume: 16 start-page: 22 year: 2014 ident: e_1_2_11_42_1 article-title: Effectiveness of the corpus callosotomy as a quirurgical treatment for the Lennox‐Gastaut syndrome publication-title: Epileptic Disord – ident: e_1_2_11_65_1 doi: 10.1111/j.1528-1157.1996.tb01820.x – ident: e_1_2_11_114_1 doi: 10.1016/j.vhri.2020.07.402 – volume: 17 start-page: S203 year: 2014 ident: e_1_2_11_67_1 article-title: Clinical demographic profile and outcome of patients with Lennox‐Gastaut syndrome (LGS) publication-title: Ann Indian Acad Neurol – ident: e_1_2_11_87_1 doi: 10.1016/j.yebeh.2021.108239 – volume: 8 issue: 6 year: 2016 ident: e_1_2_11_15_1 article-title: Development of a critical appraisal tool to assess the quality of cross‐sectional studies (AXIS) publication-title: BMJ Open doi: 10.1136/bmjopen-2016-011458 – ident: e_1_2_11_32_1 doi: 10.1016/S0387-7604(87)80098-0 – volume: 84 start-page: 30 issue: 7 year: 2015 ident: e_1_2_11_85_1 article-title: Development of a claims‐based classifier to identify Lennox‐Gastaut syndrome publication-title: Neurology – ident: e_1_2_11_28_1 doi: 10.1111/j.1528-1157.1996.tb01821.x – volume: 55 start-page: 111 year: 2014 ident: e_1_2_11_98_1 article-title: Use of adjunctive rufinamide for patients with lennox‐gastaut syndrome in clinical practice publication-title: Epilepsia – ident: e_1_2_11_37_1 doi: 10.1016/j.yebeh.2017.09.006 – ident: e_1_2_11_43_1 doi: 10.1016/j.eplepsyres.2010.01.012 – ident: e_1_2_11_46_1 doi: 10.1016/j.yebeh.2017.08.026 – ident: e_1_2_11_111_1 doi: 10.1016/j.braindev.2007.09.004 – volume: 52 start-page: 209 year: 2011 ident: e_1_2_11_116_1 article-title: Adjunctive therapy of rufinamide in Lennox‐Gastaut syndrome publication-title: Epilepsia – ident: e_1_2_11_9_1 doi: 10.1016/j.seizure.2009.06.005 – ident: e_1_2_11_77_1 doi: 10.1016/j.ejpn.2004.08.002 – ident: e_1_2_11_113_1 doi: 10.1542/peds.2018-0449 – ident: e_1_2_11_8_1 doi: 10.1111/epi.13368 – ident: e_1_2_11_44_1 doi: 10.1053/seiz.2000.0483 – ident: e_1_2_11_29_1 doi: 10.1007/s00701-016-2765-9 – ident: e_1_2_11_7_1 doi: 10.3389/fneur.2017.00505 – ident: e_1_2_11_53_1 doi: 10.1111/epi.16934 – ident: e_1_2_11_74_1 doi: 10.1016/j.yebeh.2009.07.038 – ident: e_1_2_11_83_1 doi: 10.1016/j.eplepsyres.2014.11.004 – ident: e_1_2_11_115_1 doi: 10.1016/j.braindev.2018.07.020 – ident: e_1_2_11_71_1 doi: 10.1016/j.yebeh.2020.107287 – ident: e_1_2_11_97_1 doi: 10.1016/j.jns.2013.07.057 – ident: e_1_2_11_49_1 doi: 10.1016/j.seizure.2011.02.011 – ident: e_1_2_11_38_1 doi: 10.1016/j.yebeh.2020.107253 – volume: 12 start-page: 64 year: 2012 ident: e_1_2_11_62_1 article-title: Prospective analysis of seizure freedom in established epilepsy (Abs 1.160) publication-title: Epilepsy Curr – ident: e_1_2_11_90_1 doi: 10.1016/j.jval.2012.03.772 – ident: e_1_2_11_96_1 doi: 10.1016/j.seizure.2015.10.009 – ident: e_1_2_11_79_1 doi: 10.1212/WNL.36.9.1224 – ident: e_1_2_11_70_1 doi: 10.1016/j.yebeh.2017.05.021 – ident: e_1_2_11_108_1 doi: 10.1002/epi4.12470 – volume: 50 start-page: 177 year: 2009 ident: e_1_2_11_88_1 article-title: Domains of concern for families whose child has Lennox‐Gastaut syndrome publication-title: Epilepsia – volume: 1 start-page: 146 year: 1988 ident: e_1_2_11_21_1 article-title: Long‐term prognosis and clinico‐electroencephalographic evolution of Lennox‐Gastaut syndrome publication-title: Brain Dysfunction – volume: 50 start-page: 149 year: 2009 ident: e_1_2_11_20_1 article-title: Electroclinical Semiology at Onset of the Lennox‐Gastaut Syndrome publication-title: Epilepsia – ident: e_1_2_11_84_1 doi: 10.1016/j.yebeh.2022.108586 – volume: 55 start-page: 211 year: 2014 ident: e_1_2_11_106_1 article-title: Lennox‐Gastaut syndrome in adulthood: clinical features from a long term follow‐up publication-title: Epilepsia – ident: e_1_2_11_56_1 doi: 10.4103/1817-1745.159184 – ident: e_1_2_11_27_1 doi: 10.4274/tpa.634 – ident: e_1_2_11_48_1 doi: 10.1212/WNL.92.15_supplement.P2.5-011 – ident: e_1_2_11_2_1 doi: 10.1007/s40263-020-00784-8 – ident: e_1_2_11_45_1 doi: 10.1016/j.ebr.2021.100508 – volume: 50 start-page: 711 year: 2010 ident: e_1_2_11_31_1 article-title: Lennox‐Gastaut syndrome in Spain: a descriptive retrospective epidemiological study publication-title: Rev Neurol – ident: e_1_2_11_54_1 doi: 10.1111/ane.12221 – ident: e_1_2_11_61_1 doi: 10.1186/s11689-018-9229-x – volume: 12 start-page: 60 year: 2012 ident: e_1_2_11_23_1 article-title: Cryptogenic lennox‐gastaut syndrome: phenotypic characteristics of participants in the epilepsy phenome/genome project publication-title: Epilepsy Curr – volume: 51 start-page: 173 year: 1997 ident: e_1_2_11_58_1 article-title: Mental deterioration in childhood epilepsy publication-title: Acta Med Okayama – ident: e_1_2_11_103_1 doi: 10.1016/j.yebeh.2013.08.011 – ident: e_1_2_11_12_1 doi: 10.1186/s13023-023-02626-4 – ident: e_1_2_11_25_1 doi: 10.1016/j.pediatrneurol.2013.03.016 – ident: e_1_2_11_78_1 doi: 10.1212/CPJ.0000000000000527 – ident: e_1_2_11_86_1 doi: 10.1046/j.1528-1157.2001.23900.x – volume: 33 start-page: 105 year: 1981 ident: e_1_2_11_60_1 article-title: Prognosis of Lennox‐Gastaut syndrome publication-title: Minerva Pediatr – ident: e_1_2_11_26_1 doi: 10.1111/j.1528-1157.1997.tb00065.x – ident: e_1_2_11_102_1 doi: 10.3389/fneur.2020.00409 – volume: 52 start-page: 132 year: 2011 ident: e_1_2_11_50_1 article-title: A European Registry of antiepileptic drug use in patients with Lennox‐Gastaut syndrome: update of current status publication-title: Epilepsia – volume: 52 start-page: 257 year: 2011 ident: e_1_2_11_35_1 article-title: Development of Lennox‐Gastaut syndrome in adulthood publication-title: Rev Neurol – volume: 55 start-page: 207 year: 2014 ident: e_1_2_11_64_1 article-title: Lennox‐gastaut syndrome in adult patients publication-title: Epilepsia – volume-title: Mind the gap: the evolution of Lennox–Gastaut syndrome year: 2019 ident: e_1_2_11_18_1 – ident: e_1_2_11_33_1 doi: 10.1016/j.seizure.2012.08.003 – ident: e_1_2_11_51_1 doi: 10.3349/ymj.2019.60.1.106 – volume: 21 start-page: S48 year: 2015 ident: e_1_2_11_95_1 article-title: Examining healthcare utilization and costs in patients with lennox‐gastaut syndrome: a real‐world observational study in a U.S. health plan publication-title: J Manag Care Spec Pharm – ident: e_1_2_11_66_1 doi: 10.1016/j.eplepsyres.2018.09.011 – volume: 26 start-page: S117 year: 1995 ident: e_1_2_11_81_1 article-title: Sleep‐epilepsy interactions in patients with intractable generalized tonic seizures and depth electrodes in the centro median thalamic nucleus publication-title: Arch Med Res – volume: 258 start-page: S234 year: 2011 ident: e_1_2_11_76_1 article-title: Childhood epileptic encephalopathies: cognitive and behavioural aspects publication-title: J Neurol – ident: e_1_2_11_112_1 doi: 10.1016/j.braindev.2007.07.013 – ident: e_1_2_11_59_1 doi: 10.1016/j.eplepsyres.2021.106575 – ident: e_1_2_11_4_1 doi: 10.1111/epi.17241 – ident: e_1_2_11_3_1 doi: 10.1007/s10072-017-3188-y – ident: e_1_2_11_107_1 doi: 10.1111/epi.14569 – ident: e_1_2_11_91_1 doi: 10.1016/j.jval.2019.04.1300 – ident: e_1_2_11_19_1 doi: 10.1212/WNL.90.15_supplement.P2.087 – ident: e_1_2_11_41_1 doi: 10.1100/2012/614263 – volume: 56 start-page: 169 year: 2015 ident: e_1_2_11_117_1 article-title: Effectiveness and tolerability of rufinamide in Korean children with Lennox‐Gastaut syndrome publication-title: Epilepsia – ident: e_1_2_11_17_1 doi: 10.1111/epi.13670 – ident: e_1_2_11_109_1 doi: 10.1016/j.clineuro.2012.09.021 – volume: 37 start-page: 24 year: 2018 ident: e_1_2_11_34_1 article-title: Electro‐Clinical Manifestations of Lennox‐Gastaut syndrome publication-title: Afr J Neurol Sci – volume: 41 start-page: 7 year: 2003 ident: e_1_2_11_36_1 article-title: Characteristics of clinical manifestations and EEG of Lennox‐Gastaut syndrome publication-title: J Pediatr
SSID	ssj0007673
Score	2.525186
SecondaryResourceType	review_article
Snippet	Fully elucidating the burden that Lennox–Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes... Fully elucidating the burden that Lennox-Gastaut syndrome (LGS) places on individuals with the disease and their caregivers is critical to improving outcomes...
SourceID	proquest pubmed crossref wiley
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	1224
SubjectTerms	caregiver burden Caregiver Burden - psychology Caregivers Caregivers - economics Caregivers - psychology comorbidities Comorbidity Cost of Illness Drug resistance Humans Intellectual disabilities Intellectual Disability - economics Intellectual Disability - epidemiology Intellectual Disability - psychology Intellectual Disability - therapy Lennox Gastaut Syndrome Literature reviews nonseizure symptoms Quality of Life Seizures Sleep disorders Social interactions symptom burden Systematic review
Title	A comprehensive systematic literature review of the burden of illness of Lennox–Gastaut syndrome on patients, caregivers, and society
URI	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fepi.17932 https://www.ncbi.nlm.nih.gov/pubmed/38456647 https://www.proquest.com/docview/3053153134 https://www.proquest.com/docview/2954776427
Volume	65
WOSCitedRecordID	wos001180691300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1528-1167 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007673 issn: 0013-9580 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1528-1167 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007673 issn: 0013-9580 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS9xAEB9EpfhSP1rr1Q9W6YMPXkmyuWwWn0Q9K-hxFKX3Fnb3NvXgSORyV_rom3-A_6F_iTPZJCq2UCiEkCUbdtmdj99kZmcAvqBK4lpqtE1SPmyHWpMcRH6Mo0ijwlRSCldsQvR68WAg-3NwWJ-Fcfkhmh9uxBmlvCYGV7p4weT2dvSVqAvl74Lvc0EkHYT9RgyLqHIv-7wtO7FXpRWiMJ7m09fK6A3CfA1YS43TXf6vua7A-wposiNHGaswZ7M1eHdZudI_wP0Ro3Dyib1xIezsOaczGze5lpk72sLylCFSZLo89ECt0XhMQpIeL1BW578f7x7OFELN2ZTVWRBYnrEqb2txwCjG7GcZBXLAVDZkhYsX_QjX3dOr42_tqipD23CC47EVXAWB4loJw_0g0tazqRrqztDo1PqxQURnQ0ml_4xKPd94QivUk0ZL3lERX4f5LM_sBrCOsYH0U22imHzMUhs0cFIhEUeY0FOiBfv19iSmSllOlTPGSW264MIm5cK2YK_peuvydPyp01a9x0nFqkXCSQzhxcMW7DavkcnIc6Iym8-KhJyhQqCphlP65GijGYXHiEGjkCZbksDfh09O--flw-d_77oJSwHCKBdiuQXz08nMbsOi-TUdFZOdkuLxLgbxDiycfO9eX2Drx3nvCfL-CJk
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEB7CJrS9tOn_tkmqlhx6yBbbsi0LeglNtgndLKEkkJuRtHK7sNhhvVt6zC0P0Dfsk3TGkt2EJFAo-CBjGQlpfr7RjGYAtlElcS012iYFnwxirUkOIj9maapRYSophSs2Icbj7OxMHq_Ax_YujMsP0R24EWc08poYnA6kr3C5PZ9-IPJCAbwaIxklPVjd-zo8HXWSWKTewxzygUyywGcWokie7ufr-ugGyLyOWRulM3z0f9Ndh4cebLJdRx2PYcWWT-DekXenP4XLXUYh5XP73YWxs795ndmsy7fM3PUWVhUM0SLTzcUHepvOZiQoqTlCeV39_H3x67NCuLlcsDYTAqtK5nO31juM4sy-NZEgO0yVE1a7mNFncDrcP_l0MPCVGQaGEyTPrOAqihTXShgeRqm2gS3URCcTowsbZgZRnY0llf8zqghCEwitUFcaLXmiUv4cemVV2pfAEmMjGRbapBn5maU2aOQUQiKWMHGgRB_et_uTG5-2nKpnzPLWfMGFzZuF7cO7ruu5y9VxW6eNdpNzz651zkkU4cPjPrztPiOjkfdElbZa1jk5RIVAcw2n9MIRRzcKzxCHpjFNtqGBu4fP948Pm8arf-_6Bu4fnByN8tHh-MtreBAhrHIhlxvQW8yXdhPWzI_FtJ5veQb4A6ubCn8
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4hQKiXFvqgWx51qx56YKskTuJY4oKApah0tYdW4hbZjlNWWiWrzS7iyI0fwD_klzATJ2kRRapUKQdHcRTLnsc3mfFngE_okriWGmOTnGf9UGuyg6iPSRxrdJhKSuEOmxDDYXJ-LkdLsN_uhXH8EN0PN9KM2l6Tgttplv-h5XY6_kLihQZ4JYzQxhKvczjq7LCIm_yyz_sySryGV4jqeLpXH3qjRxDzIWKtXc7gxf8Ndh2eN1CTHTjZ2IAlW7yEte9NMv0V3BwwKiif2QtXxM5-szqzSce2zNzmFlbmDLEi0_W2B7obTyZkJql5hta6vLq7vj1RCDYXc9byILCyYA1za7XHqMrsV10HssdUkbHKVYy-hp-D4x-HX_vNuQx9wwmQJ1ZwFQSKayUM94NYW8_mKtNRZnRu_cQgprOhpMP_jMo933hCK_SURkseqZi_geWiLOxbYJGxgfRzbeKEssxSGwxxciERSZjQU6IHn9v1SU1DWk5nZ0zSNnjBiU3rie3Bx67r1DF1_K3TdrvIaaOsVcrJEOHFwx586B6jmlHuRBW2XFQppUOFwGANh7TphKP7Ck8QhcYhDbaWgac_nx6PTuvGu3_v-h7WRkeD9Ox0-G0LngWIqVy95TYsz2cLuwOr5nI-rma7tfTfA3WbCGg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comprehensive+systematic+literature+review+of+the+burden+of+illness+of+Lennox-Gastaut+syndrome+on+patients%2C+caregivers%2C+and+society&rft.jtitle=Epilepsia+%28Copenhagen%29&rft.au=Cross%2C+J+Helen&rft.au=Ben%C3%ADtez%2C+Arturo&rft.au=Roth%2C+Jeannine&rft.au=Andrews%2C+J+Scott&rft.date=2024-05-01&rft.eissn=1528-1167&rft.volume=65&rft.issue=5&rft.spage=1224&rft_id=info:doi/10.1111%2Fepi.17932&rft_id=info%3Apmid%2F38456647&rft.externalDocID=38456647
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9580&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9580&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9580&client=summon